Plus: Should you sell your homecare business?
Unsubscribe | View in browser
Here’s a bit of clinical news on the oxygen front: A new study found that COVID-19 patients treated with home oxygen were unlikely to return to the hospital or die. The study, published in JAMA Network Open, looked at 621 patients discharged from the hospital and treated at home for 30 days and concluded that home oxygen ensured “the right care in the right place at the right time.” You can read it here

The median age of patients in the study was 51, which is relevant given that the Centers for Disease Control is reporting more people in their 30s and 40s are being hospitalized with severe symptoms.

Meanwhile, demand for protective masks is sky-high. Make that demand for real masks: Customs officials say that they've seized millions of counterfeit N-95 masks, and the numbers are increasing exponentially. That includes two recent seizures of almost 200,000 fake masks bearing 3M's logo. Read more. 


O2 Travel Season Depends On the Eclipse 5 TOC
The clinically-proven Eclipse 5 transportable oxygen concentrator is the go-to travel solution for oxygen users. Contact your sales representative today to learn more about this all-in-one unit offering pulse and continuous flow options, and the accessories perfect for travel and your rental fleet. For 50 years, CAIRE has been designing and delivering the best technologies to support oxygen therapy.
Learn More


Industry News



Revenue Cycle Management (RCM) touches every aspect of your business, from referral through payment posting. This white paper from TIMS Software shares ways RCM software can help your bottom line. Click here to download now.


Homecare’s Value is Up—Should You Sell?
The market value of durable medical equipment companies and home health agencies is currently hitting record highs. So should you sell? Read on to learn what buyers are looking for.

Please note: You may be on other email lists and may continue to receive messages not related to HomeCare Now.
Unsubscribe from other lists individually. The reply-to mailbox is not monitored.

Our email practices are designed to comply with the EU’s General Data Protection Regulation (GDPR) and other privacy laws around the world. Read about HomeCare's data privacy policy online.